The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour
Open Access
- 28 May 2020
- journal article
- research article
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2020, 1-9
Abstract
The expression of TFE3 (transcription factor E3) in solitary fibrous tumours (SFTs) and their histologic mimickers was investigated, and the diagnostic value and clinical significance of TFE3 nuclear expression in SFTs were explored. Immunohistochemical analysis for TFE3 was performed on 50 cases of SFTs that were surgically resected. The controls were sample tissues from malignant peripheral nerve sheath tumour, synovial sarcoma, dedifferentiated liposarcoma, spindle cell lipoma, and dermatofibrosarcoma protuberans. The survival of patients with TFE3-positive and TFE3-negative expressions was assessed through the Kaplan-Meier analysis. In 44 of 50 (88%) SFTs, nuclear immunoreactivity for TFE3 was detected. The TFE3 expression was negative in all samples of synovial sarcoma, malignant peripheral nerve sheath tumour, dermatofibrosarcoma protuberans, and spindle cell lipoma and weakly positive in 2 of 10 cases of dedifferentiated liposarcoma. Fluorescence in situ hybridization (FISH) confirmed that the expression of the TFE3 protein is not caused by gene translocation. There was no statistical significance between the association of the TFE3 expression and SFT patient prognosis. Therefore, TFE3 is capable of enhancing the differential diagnosis of SFTs and their histologic mimickers and can be potentially used as a diagnostic marker. The findings also offer valuable insights into SFT diagnosis, aetiology, and associated molecular mechanisms.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (17ZR1417500)
This publication has 29 references indexed in Scilit:
- Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimicsLaboratory Investigation, 2014
- Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencingNature Genetics, 2013
- A Distinctive Subset of PEComas Harbors TFE3 Gene FusionsAmerican Journal of Surgical Pathology, 2010
- Expanding the Spectrum of Malignant Progression in Solitary Fibrous TumorsAmerican Journal of Surgical Pathology, 2009
- Pediatric Renal Cell CarcinomaAmerican Journal of Clinical Pathology, 2006
- Melanocytes and theMicrophthalmiaTranscription Factor NetworkAnnual Review of Genetics, 2004
- Atypical and Malignant Solitary Fibrous Tumors in Extrathoracic LocationsAmerican Journal of Surgical Pathology, 1998
- Malignant solitary fibrous tumour of the peritoneumHistopathology, 1996
- Solitary Fibrous Tumor Consistent CD34 Immunoreactivity and Occurrence in the OrbitAmerican Journal of Surgical Pathology, 1994
- HEMANGIOPERICYTOMA A VASCULAR TUMOR FEATURING ZIMMERMANNʼS PERICYTESAnnals of Surgery, 1942